Growth hormone and exercise: physiology, use and abuse (Q34349480)

1 August 2017

1 reference

title

Growth hormone and exercise: physiology, use and abuse (English)

1 reference

1 August 2017

0 references

Jenkins PJ

1

1 reference

1 August 2017

publication date

1 June 2001

1 reference

Growth Hormone & I G F Research

1 August 2017

published in

1 reference

1 August 2017

volume

11 Suppl A

1 reference

1 August 2017

page(s)

S71-7

1 reference

Changes in prolactin and growth hormone levels during hypoxia and exercise

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Responses of IGF-I to endogenous increases in growth hormone after heavy-resistance exercise.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Hormonal secretion during nighttime sleep indicating stress of daytime exercise

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Nocturnal hormonal responses to resistance exercise

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Human growth hormone response to repeated bouts of aerobic exercise

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Effects of endurance exercise on nocturnal hormone concentrations in males

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Plasma beta-endorphin, corticotrophin and growth hormone responses to exercise in pubertal and prepubertal children

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Endurance training effects on plasma hormonal responsiveness and sex hormone excretion

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Growth hormone in exercise: comparison of physiological and pharmacological stimuli

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Differences in the metabolic and hormonal response to exercise between racing cyclists and untrained individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

The role of opioid peptides in the hormonal responses to acute exercise in man.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Naloxone inhibits exercise-induced release of PRL and GH in athletes

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Effect of the enhancement of the cholinergic tone by pyridostigmine on the exercise-induced growth hormone release in man

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Cholinergic but not serotonergic mediation of exercise-induced growth hormone secretion

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Influence of endogenous cholinergic tone and growth hormone-releasing peptide-6 on exercise induced growth hormone release

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

The effect of different diets and of insulin on the hormonal response to prolonged exercise

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Prolactin, growth hormone, thyrotropin, 3,5,3'-triiodothyronine, and thyroxine responses to exercise after fat- and carbohydrate-enriched diet

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Influence of carbohydrate supplementation early in exercise on endurance running capacity

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Influence of mode and carbohydrate on the cytokine response to heavy exertion

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Exercise-induced changes in insulin-like growth factors and their low molecular weight binding protein in healthy subjects and patients with growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Effect of brief exercise on circulating insulin-like growth factor I.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Changes in hormonal concentrations after different heavy-resistance exercise protocols in women.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Hormonal and growth factor responses to heavy resistance exercise protocols

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Effect of endurance exercise on somatomedin-C/insulin-like growth factor I concentration in male and female runners

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Effects on glucose tolerance, insulin secretion, insulin-like growth factor 1 and its binding protein, IGFBP-1, in a randomized controlled diet and exercise study in healthy, middle-aged men.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Growth Hormone and Insulin-Like Growth Factor I Responses to Moderate Submaximal Acute Physical Exercise in Man: Effects of Octreotide, a Somatostatin Analogue, Administration

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Hormonal responses to exercise and training: a short review

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Somatomedin-C, physical fitness, and bone density

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Influence of physical activity on insulin-like growth factor-I in healthy younger and older men.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Effect of regular physical training on age-associated alteration of body composition in men.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Plasma Insulin-Like Growth Factor-I and High Affinity Growth Hormone-Binding Protein Levels Increase After Two Weeks of Strenuous Physical Training

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Endurance training and its effect upon the activity of the GH-IGFs system in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Insulin-like growth factor immunoreactivity increases in muscle after acute eccentric contractions

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Effect of growth hormone suppression on exercise training and growth responses in young rats

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Effect of training and growth hormone suppression on insulin-like growth factor I mRNA in young rats

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Lack of effect of recombinant human growth hormone (GH) on muscle morphology and GH-insulin-like growth factor expression in resistance-trained elderly men.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Growth hormone treatment in growth hormone-deficient adults. I. Effects on muscle mass and strength

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Replacement treatment with biosynthetic human growth hormone in growth hormone-deficient hypopituitary adults

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Cardiovascular effects of prolonged growth hormone replacement in adults.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Three years of growth hormone treatment in growth hormone-deficient adults: near normalization of body composition and physical performance

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Effects of short term administration of recombinant human growth hormone to elderly people

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Effects of human growth hormone in men over 60 years old

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Octreotide treatment increases exercise capacity in patients with acromegaly

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Muscle changes in acromegaly.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Effect of growth hormone treatment on hormonal parameters, body composition and strength in athletes

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Growth hormone induced increase in serum IGFBP-3 level is reversed by anabolic steroids in substance abusing power athletes

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Increase in haemoglobin concentrations in growth hormone deficient adults during human recombinant growth hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Acromegaly, colonic polyps and carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

1 reference

7 January 2021

Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Self-administration of cadaveric growth hormone in power athletes

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Isotopic differences in human growth hormone preparations

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Growth hormone and sport: abuse, potential benefits, and difficulties in detection

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Serum IGF‐I and IGF binding proteins 2 and 3 as potential markers of doping with human GH

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Detection of doping with human growth hormone

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Biochemical markers of bone and collagen turnover in acromegaly or Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

Long-term effects of octreotide on markers of bone metabolism in acromegaly: evidence of increased serum parathormone concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980012-5

7 January 2021

10.1016/S1096-6374(01)80012-5

Identifiers

DOI

1 reference

1 August 2017

1 reference